Breaking News
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
March 22, 2019 - Pitt engineers win $550,000 NSF CAREER award to develop new intervention for people with ASD
March 22, 2019 - Early discharge does not increase readmission risk for patients after lung surgery
March 22, 2019 - Creating diverse pool of trained scientists to address Alzheimer’s research needs
March 22, 2019 - Surprising discovery offers clues to limit graft-vs.-host disease
March 22, 2019 - Study shows ACA’s positive impact on healthcare affordability and access for women
March 22, 2019 - Study provides new pathway for controlling inflammation
March 22, 2019 - New combination treatment shows promise for common brain tumor in children
March 22, 2019 - Virginia Tech Helmet Lab releases first youth-specific football helmet ratings
March 22, 2019 - New algae-based treatment could reduce need for limb amputation
March 22, 2019 - Stroke risk reduces in both black and white older Medicare beneficiaries, study reports
March 22, 2019 - City of Hope exhibits current studies and data on cancer therapies at AACR
March 22, 2019 - New study identifies CD40 molecule as key entry point for dangerous bacteria
March 22, 2019 - Health Tip: Six Steps to a Healthier Life
March 22, 2019 - even a little activity helps you live longer
March 22, 2019 - Many individuals recovering from addiction continue to suffer from chronic physical disease
March 22, 2019 - New drugs on PBS for Parkinson’s, MND and Cutaneous T cell lymphoma
March 22, 2019 - Saving energy also saves lives, UW-Madison study says
March 22, 2019 - Former inmates who receive social support have better mental health, study finds
March 22, 2019 - Nanofibrous membrane could enhance periodontal tissue regeneration
March 22, 2019 - Anti-vaxxer Italian leader down with chickenpox
March 22, 2019 - Servier collaborates with Harvard researchers to fight metabolic diseases
March 22, 2019 - National Eating Disorders Association
March 22, 2019 - Pumping up red blood cell production
March 22, 2019 - Excessive phosphate fertilizer may hurt plants by altering microbial composition in soil
March 22, 2019 - Medical marijuana laws could be improving older Americans’ health, study suggests
March 22, 2019 - Study indicates the benefits of stopping aspirin in heart attack patients
March 22, 2019 - Deep brain stimulation offers significant relief for patients with treatment-resistant depression
March 22, 2019 - Mental health problems in young adults on the rise
March 22, 2019 - Innovative membrane offers a viable solution for periodontitis
March 22, 2019 - The FDA Grants Rare Pediatric Disease Designation to Odiparcil for the Treatment of MPS VI
March 22, 2019 - insulin therapy: MedlinePlus Medical Encyclopedia
March 22, 2019 - Guidelines on the use of genetic testing in psychiatry
March 22, 2019 - Aspiring Doctors Seek Advanced Training In Addiction Medicine
March 22, 2019 - A change in focus could enable the development of new treatments for Alzheimer’s disease
March 22, 2019 - A new way to visualize the immune cell “landscape” of bowel cancer tumors
March 22, 2019 - Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia
March 22, 2019 - Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019
March 22, 2019 - Less invasive valve replacement can be safe and effective alternative for healthier patients
March 22, 2019 - Aphasia research reveals new, complex interactions between thought and language
March 22, 2019 - Artificial neural networks can predict how different areas in the brain respond to words
March 22, 2019 - Age-related changes to gut microbiome have adverse impact on vascular health, study shows
March 22, 2019 - Study provides new insight into blood cell and immune cell production
March 22, 2019 - Isolated seniors chat online to prevent cognitive decline
March 22, 2019 - Repurposing drugs to outsmart cancers
March 22, 2019 - Naltrexone implant more effective in reducing relapses in HIV patients with opioid addiction
March 22, 2019 - The Brain Institute wins $7.04 million grant to investigate ‘neurophilosphy of free will’
March 22, 2019 - Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application
March 22, 2019 - Eruptive xanthomatosis
March 22, 2019 - Cause of vascular disease in kidney failure reversed in animal model
March 22, 2019 - Researchers discover possible new therapeutic strategy for pancreatic cancer
March 22, 2019 - Ebola spreads to second largest city in DRC
March 22, 2019 - Perivascular spaces contribute to worse cognitive health in older adults
March 22, 2019 - Adolescent daily users more likely to obtain electronic cigarettes from commercial sources
March 22, 2019 - FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer
March 22, 2019 - Diabetes myths and facts: MedlinePlus Medical Encyclopedia
March 22, 2019 - TGen and ABL pursue global rollout of advanced TB test
March 22, 2019 - Traffic light labels influence people to choose healthier and more sustainable meals
March 22, 2019 - Alzheimer’s patients using antiepileptic drugs have twice the risk of pneumonia, study shows
NUS researchers make muscle recovery easier for patients with ingenious medical device

NUS researchers make muscle recovery easier for patients with ingenious medical device

image_pdfDownload PDFimage_print

Non-invasive magnetic stimulation ‘tricks’ muscle cells into thinking that they are exercising, and amplifies the biological effect to promote muscle regeneration

The journey of muscle rehabilitation can be long and arduous, and requires strong perseverance from the patient. Now, researchers from the National University of Singapore (NUS) are making the recovery process much easier for patients with an ingenious medical device capable of regenerating muscles in a non-invasive and painless manner. The device, named MRegen, makes use of specific magnetic field to trigger and amplify the biological effect of exercise, hence accelerating muscle recovery.

The earth is cloaked in a protective magnetic field which is believed to have enabled life to evolve. Its ability to influence human development has prompted scientists and biomedical companies to seek ways to harness magnetic fields for therapeutic purposes. While creating a magnetic field is simple, the ability to generate the appropriate magnetic stimulation that triggers a positive therapeutic effect is technologically challenging.

A team of NUS researchers led by Associate Professor Alfredo Franco-Obregón studied the effects of magnetic fields on muscle cells. By coupling two fundamental concepts – firstly, muscle development is regulated by energy production; and secondly, energy management is extremely sensitive to magnetic fields – the researchers developed MRegen which makes use of a unique magnetic field to activate energy production and trigger muscle regeneration. The energy produced via the magnetic stimulation ‘tricks’ muscle cells into thinking that they are exercising, hence activating them to adapt and improve at an accelerated speed.

Assoc Prof Franco-Obregón, who is from the Department of Surgery at Yong Loo Lin School of Medicine and the Biomedical Institute for Global Health Research and Technology at NUS, explained, “The device provides a uniform electromagnetic field to a muscle area at a magnitude and pulse duration that reproduces the same regenerative, energetic and metabolic responses as physical activity. The duration of use for the device has been optimised for providing the largest therapeutic effect in terms of muscle equality, function and metabolic stability. The device is especially useful in reducing muscle degradation in periods when physical activity is not possible.”

Promising results in two clinical trials

MRegen has shown promising results in two human trials conducted between 2015 and 2017.

The first human trial examined the effects of MRegen on healthy individuals by giving 10 recruited healthy individuals the magnetic field treatment in either their left or right leg. The researchers found that those who received 10 minutes of magnetic stimulation by MRegen once a week for five consecutive weeks showed an average of 30 to 40 per cent improvement in muscle strength, in both legs.

The second human trial examined the effectiveness of MRegen in accelerating the muscle recovery of patients who had undergone anterior cruciate ligament (ACL) knee surgery at a local hospital. In this trial, 10 recruited patients were given the normal rehabilitation therapy while 10 other patients were given the magnetic field treatment with MRegen in addition to the rehabilitation therapy. It was observed that the patients who were treated with MRegen experienced a recovery in muscle size and strength in their operated leg four weeks earlier than those who had undergone only the normal rehabilitation procedures. Most notably, Magnetic Resonance Imaging measurements showed that muscle metabolism, one of the strongest indicators of muscle health and regenerative capacity, improved by up to 50 percent in the patients who had undergone MRegen’s magnetic field treatment.

Field treatment in one leg has also consistently appeared to have positively influenced the health of the other leg in both trials, demonstrating what is known as a contralateral effect. Such an effect has been described in the sports science field, but not as strongly observed as with MRegen’s magnetic field therapy. Furthermore, those who received the magnetic field treatment showed no sign of discomfort or adverse consequences, proving the treatment to be a painless procedure. This breakthrough medical device could therefore shift the paradigm of current muscle rehabilitation routine and make the road to recovery shorter and more comfortable for patients.

The researchers filed a patent for this novel technology and have since spun off a company, QuantumTX, to commercialize it. They believe that the technology holds great promise for slowing muscle loss and maintaining healthy muscle metabolism in the frail and elderly, as well as helping to maintain muscle mass for professional athletes during detraining. The NUS team is also looking into applying the same technology for treating other health conditions such as obesity and diabetes, and early stages of their research have already shown encouraging results.

“Muscle makes up 40 per cent of an average person’s body mass, and plays a major role in regulating one’s body, health and longevity. If we can harness the ability to regulate muscle development, we may gain greater control of the overall human health. MRegen, which has proven to be non-invasive and effective in regenerating muscles, can be easily modified to treat other human diseases. We foresee this technology playing an important role in disease treatment in the future,” said Assoc Prof Franco-Obregón.

Source:

https://news.nus.edu.sg/press-releases/MRegen

Tagged with:

About author

Related Articles